Multi‑omics approach to improve patient‑tailored therapy using immune checkpoint blockade and cytokine‑induced killer cell infusion in an elderly patient with lung cancer: A case report and literature review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multi‑omics approach to improve patient‑tailored therapy using immune checkpoint blockade and cytokine‑induced killer cell infusion in an elderly patient with lung cancer: A case report and literature review

Published:2024-03-11 Issue:5 Volume:27 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Xing Yasi¹,Qin Fangyuan¹,Han Lei¹,Yang Jingwen¹,Zhang Hongrui²,Qi Yong³,Tu Shichun²,Zhai Yaping¹

Affiliation:

1. Henan Eye Institute, Henan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan 450001, P.R. China

2. Zhengzhou Shenyou Biotechnology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan 450001, P.R. China

3. Department of Respiratory and Critical Care Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan 450001, P.R. China

Publisher

Spandidos Publications

Reference39 articles.

1. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

2. Cancer statistics for the year 2020: An overview;Ferlay;Int J Cancer,2021

3. Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review;Sosa;CA Cancer J Clin,2021

4. Immunotherapy comes of age in lung cancer;Khanna;Clin Lung Cancer,2017

5. The role of immunotherapy in the first-line treatment of elderly advanced non-small cell lung cancer;Spagnuolo;Cancers (Basel),2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP